低分子肝素治疗急性冠状动脉综合征62例疗效分析

Analysis on Curative Effect of Low Molecular Heparin in Treatment of 62 Cases Acute Coronary Artery Syndrome

目的探讨常规药物治疗的基础上加用低分子肝素治疗急性冠状动脉综合征的疗效。方法选取该院2010年4月—2012年3月收治的急性冠状动脉综合征患者62例,随机分为两组,观察组32例常规药物治疗的基础上加用低分子肝素,对照组30例仅给予常规治疗。观察两组患者治疗期间心绞痛的发作情况以及心电图变化情况,比较两组的治疗效果。结果经比较观察组的治疗效果优于对照组,差异有统计学意义(P<0.05)。结论低分子肝素联合常规药物治疗急性冠状动脉综合症疗效显著。

Objective To explore the basis of routine therapy and with low molecular heparin in treatment of acute coronary artery syndrome of the curative effect. Methods Select from April 2010 to March 2012 patients of acute coronary syndrome patients 62 cases were randomly divided into two groups, the observation group 32 cases the basis of routine therapy and with low molecular heparin group, 30 patients were only given conventional treatment. The two groups were observed during treatment angina pectoris attack condition and electrocardiogram （ecg） changes, compared with two groups of treatment effect. Results By comparison to observe the therapeutic effect of group was better than that of control group （P〈0.05）. Conclusion Low molecular heparin combined conventional drug in the treatment of acute coronary artery syndrome curative effect is distinct.